2020/21 Invitation to Tender: For health care professionals
Source: Pharmac
PHARMAC is seeking feedback from medical groups, DHB hospital pharmacies and other interested parties on:
A proposal to tender certain pharmaceuticals for principal supply;
The...
2020/21 Invitation to Tender: For Suppliers
Source: Pharmac
PHARMAC is seeking feedback from pharmaceutical suppliers and interested parties on:
A proposal to tender certain pharmaceuticals for principal supply;
The implications of awarding Principal...
2020/21 Invitation to Tender: For Patients
Source: Pharmac
PHARMAC has released the draft 2020/21 Invitation to Tender for consultation and is welcoming feedback from patient groups and the public by 4...
PHARMAC considering a new way of contracting for medicines
Source: Pharmac
Consultation has gone out today to health professionals and is available on PHARMAC’s website for anyone wanting to have their say about our...
Delay in decision on modifying funded access to mifepristone and misoprostol proposal
Source: Pharmac
PHARMAC would like to advise all interested parties that there will be a delay in the decision on a proposal to list mifepristone in...
OIA response: Vinorelbine
Source: Pharmac
31 March 2020
Dear
REQUEST FOR INFORMATION
Thank you for your email of 3 March 2020, requesting information under the Official Information Act 1982 (OIA). ...
March 2020 tender notification
Source: Pharmac
Alfacalcidol
Cap 0.25 mcg
Alfacalcidol
Cap 1 mcg
Alfacalcidol
Oral drops 2 mcg per ml
Alprostadil
Inj 10 mcg
Alprostadil
Inj 20 mcg
Betamethasone Dipropionate
Crm 0.05% in propylene glycol base
Betamethasone Dipropionate
Oint 0.05% in...
Decision to fund ivacaftor (Kalydeco) for people with cystic fibrosis with the G551D mutation
Source: Pharmac
What we’re doing
We are pleased to announce a decision to fund ivacaftor (Kalydeco) for the treatment of people with cystic fibrosis with the...
Decision to change the funded brand of labetalol tablets
Source: Pharmac
What we’re doing
PHARMAC has made a decision to make changes to the funded brand of labetalol tablets, which may be used in the...
RFP – supply of diabetes agents: SGLT-2 inhibitors, GLP-1 agonists and DPP-4 inhibitors –...
Source: Pharmac
If you wish to submit a proposal, you must submit it to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz(external link)) no...
Decision to list medical devices supplied by Hologic (Australia & New Zealand) Pty Limited
Source: Pharmac
Our response to what you told us
We appreciate the time people took to respond to this consultation.
A summary of the main themes raised...
Decision for funding in the blood, alimentary and immunosuppressant therapy areas
Source: Pharmac
Ticagrelor for prevention of thrombosis post-neurological stenting
Any changes to the original proposal?
As a result of consultation feedback and additional clinical advice, the Special...
